Aurobindo Pharma gains after American subsidiary inks product development pact with global pharma major
Aurobindo Pharma added 1.44% to Rs 1241.30 after the company's wholly owned subsidiary Aurobindo Pharma USA Inc entered into a collaboration and license agreement with a global pharma major.